Great news from our Health3-2-1 company!

SEQURNA participated in the Festival of Genomics & Biodata in London, a leading international conference connecting industry, academic, clinical, and healthcare stakeholders across genomics, diagnostics, and translational research.

The participation was supported by Interreg Health3-2-1, enabling SEQURNA to set up a booth and engage directly with key UK and international stakeholders and accelerate market entry efforts.

The quality of engagement translated rapidly into outcomes: within two weeks post-conference, two industry leads were converted into concrete opportunities, with several additional discussions progressing toward collaboration or commercial evaluation.

Participation in the Festival of Genomics & Biodata, supported by Interreg Health3-2-1, proved highly effective in accelerating SEQURNA’s UK market visibility and new commercial traction. The conference demonstrated that targeted international genomics events are a powerful mechanism for entering new markets and converting visibility into tangible outcomes.

Congratulations from the Health3-2-1 team! ✨